Spectrum Pharmaceuticals, Inc. (SPPI) Social Stream
Spectrum Pharmaceuticals Inc (SPPI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Spectrum Pharmaceuticals Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 38 weeks, SPPI's average price target has gone down $3.45.
SPPI reports an average of 195.98% for its upside potential over the past 20 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SPPI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SPPI as an investment opportunity.
- In the context of all US stocks, Spectrum Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 194.06% of them.
- SPPI has a lower variance in analysts' estimates than -89.04% of all US stocks.
- In terms of how Spectrum Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 5.88% of that group.
- In terms of how Spectrum Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 25.63% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Spectrum Pharmaceuticals Inc are PSTI, BOLT and EPZM.
Make investment decisions regarding SPPI using the data that counts. Try POWR Ratings for free.